TRAIL Modulates the Immune System and Protects against the Development of Diabetes
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TRAIL Modulates the Immune System and Protects against the Development of Diabetes
Authors
Keywords
-
Journal
Journal of Immunology Research
Volume 2015, Issue -, Pages 1-12
Publisher
Hindawi Limited
Online
2015-02-19
DOI
10.1155/2015/680749
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ACE2 deficiency shifts energy metabolism towards glucose utilization
- (2015) Stella Bernardi et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- TRAIL–Receptor Costimulation Inhibits Proximal TCR Signaling and Suppresses Human T Cell Activation and Proliferation
- (2014) Corinna Lehnert et al. JOURNAL OF IMMUNOLOGY
- Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes
- (2014) Stella Bernardi et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- The levels of circulating TRAIL at the onset of type 1 diabetes are markedly decreased in patients with ketoacidosis and with the highest insulin requirement
- (2013) Gianluca Tornese et al. ACTA DIABETOLOGICA
- Crosstalk between apoptosis, necrosis and autophagy
- (2013) Vassiliki Nikoletopoulou et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- On the TRAIL of obesity and diabetes
- (2013) Hanis H. Harith et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation
- (2012) S Jouan-Lanhouet et al. CELL DEATH AND DIFFERENTIATION
- TNF-related apoptosis-inducing ligand significantly attenuates metabolic abnormalities in high-fat-fed mice reducing adiposity and systemic inflammation
- (2012) Stella Bernardi et al. CLINICAL SCIENCE
- TRAIL as Biomarker and Potential Therapeutic Tool for Cardiovascular Diseases
- (2012) Stella Bernardi et al. CURRENT DRUG TARGETS
- Potential Role of TRAIL in the Management of Autoimmune Diabetes Mellitus
- (2012) Stella Bernardi et al. CURRENT PHARMACEUTICAL DESIGN
- A seminal monograph: Mackay and Burnet's Autoimmune diseases
- (2012) Peter J Roberts-Thomson et al. MEDICAL JOURNAL OF AUSTRALIA
- Re-establishing immunological self-tolerance in autoimmune disease
- (2012) Shimon Sakaguchi et al. NATURE MEDICINE
- Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes
- (2012) Julien Diana et al. NATURE MEDICINE
- Adaptive immunity in obesity and insulin resistance
- (2012) Henrike Sell et al. Nature Reviews Endocrinology
- State of Art and Recent Developments of Anti-Cancer Strategies Based on TRAIL
- (2012) Stella Bernardi et al. Recent Patents on Anti-Cancer Drug Discovery
- TNF-related apoptosis-inducing ligand (TRAIL) protects against diabetes and atherosclerosis in Apoe −/− mice
- (2011) B. A. Di Bartolo et al. DIABETOLOGIA
- TRAIL and DcR1 Expressions Are Differentially Regulated in the Pancreatic Islets of STZ- versus CY-Applied NOD Mice
- (2011) Ercument Dirice et al. Experimental Diabetes Research
- TRAIL shows potential cardioprotective activity
- (2011) Barbara Toffoli et al. INVESTIGATIONAL NEW DRUGS
- Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies
- (2011) Tom L. Van Belle et al. PHYSIOLOGICAL REVIEWS
- TRAIL upregulates decoy receptor 1 and mediates resistance to apoptosis in insulin-secreting INS-1 cells
- (2010) Soojeong Kang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Extreme lymphoproliferative disease and fatal autoimmune thrombocytopenia in FasL and TRAIL double-deficient mice
- (2010) L. M. Sedger et al. BLOOD
- Treatment With Recombinant Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Alleviates the Severity of Streptozotocin-Induced Diabetes
- (2010) G. Zauli et al. DIABETES
- Systemic Delivery of TNF-Related Apoptosis-Inducing Ligand (TRAIL) Elevates Levels of Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) and Prevents Type 1 Diabetes in Nonobese Diabetic Mice
- (2010) Soojeong Kang et al. ENDOCRINOLOGY
- Dual Effects of TRAIL in Suppression of Autoimmunity: The Inhibition of Th1 Cells and the Promotion of Regulatory T Cells
- (2010) T. Ikeda et al. JOURNAL OF IMMUNOLOGY
- Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets
- (2010) Barbara Toffoli et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Prevalence of Diabetes among Men and Women in China
- (2010) Wenying Yang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hematopoietic Cell-Specific Deletion of Toll-like Receptor 4 Ameliorates Hepatic and Adipose Tissue Insulin Resistance in High-Fat-Fed Mice
- (2009) Maziyar Saberi et al. Cell Metabolism
- From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
- (2009) R. A. DeFronzo DIABETES
- Normalization of obesity-associated insulin resistance through immunotherapy
- (2009) Shawn Winer et al. NATURE MEDICINE
- Role of full-length osteoprotegerin in tumor cell biology
- (2008) G. Zauli et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Inhibits Experimental Autoimmune Thyroiditis by the Expansion of CD4+CD25+Regulatory T Cells
- (2008) Su He Wang et al. ENDOCRINOLOGY
- To kill a tumor cell: the potential of proapoptotic receptor agonists
- (2008) Avi Ashkenazi et al. JOURNAL OF CLINICAL INVESTIGATION
- Cell cycle regulation by FasL and Apo2L/TRAIL in human T-cell blasts. Implications for autoimmune lymphoproliferative syndromes
- (2008) Alberto Bosque et al. JOURNAL OF LEUKOCYTE BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search